ArticleNPJ breast cancer2024

Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer.

Nicholas Mai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.